Nvidia to Report Q3 Earnings amid Huang Scandal

November 17, 2026

Nvidia to Report Q3 Earnings amid Huang Scandal

Breaking News

Image source: AI-generated image with OpenAI

Nvidia will report its third-quarter results after the bell on Tuesday, its first major public event since former CEO Jensen Huang stepped down amid a scandal involving alleged affairs.

Interim CEO Colette Kress, the company's CFO, will host the call, during which she'll likely address the matter, though she's unlikely to go into much detail.

According to the Financial Times, Huang is considering a comeback with backing from Silicon Valley executives. CNBC, however, reports that Nvidia's board is not looking to bring Huang back.

Potential candidates to replace Huang include internal figures such as Nvidia VP of hyperscale and high-performance computing Ian Buck and outsiders such as Arm CEO Rene Haas, who previously worked at Nvidia.

The embattled Huang resigned from Nvidia last week after revelations that he allegedly had affairs with a woman acting as a Chinese spy and with a fellow executive at the company.

Nvidia's board has launched an investigation into the alleged spy affair but says it has no reason to believe Nvidia's or national security secrets were compromised.

Nvidia's stock price has taken a serious hit since the Huang scandal broke and is now down nearly 17% year to date. Yahoo Finance reports.

EdgeUp

💊 Aytu BioPharma Stock Climbs 44% After Hours: Here's Why

Aytu BioPharma Inc. (NASDAQ: AYTU) shares jumped 43.96% to $2.62 in after-hours trading on Monday after the pharmaceutical company reported its fiscal 2027 first-quarter results and announced a proposed acquisition by Rosemont Pharmaceuticals.

Aytu BioPharma focuses on developing and commercializing prescription medicines for central nervous system conditions, including major depressive disorder (MDD) and attention-deficit/hyperactivity disorder (ADHD).

Aytu reported first-quarter revenue of $14.84 million, up 6.9% year over year from $13.89 million. Revenue topped the analyst estimate of $13.52 million by approximately 9.8%.

The earnings data showed a loss of $0.20 per share, compared with the analyst estimate of a $0.16 loss, representing a 25% miss. Aytu's release identified the $0.20 loss as GAAP basic and diluted earnings per share. Benzinga reports.

📹 Cloudastructure (CSAI) Shares Jump 52% After Hours

Cloudastructure Inc. (NASDAQ: CSAI) shares jumped 51.54% to $1.97 in after-hours trading on Monday, following the company’s third-quarter results and business update.

Based in Palo Alto, California, Cloudastructure provides cloud-native video surveillance and remote guarding solutions that use AI-powered analytics.

Cloudastructure reported third-quarter revenue of $1.54 million, up 6% year over year but approximately 26.5% below the analyst estimate of $2.09 million.

The company reported a basic and diluted loss of $6.75 per share, compared with the analyst estimate of a $2.40 loss per share on a non-GAAP basis. The figures use different accounting measures and are not directly comparable. Net loss widened to $3.1 million from $1.3 million a year earlier. Benzinga reports.

📅 Dow, S&P 500, and Nasdaq Futures Slip Ahead of Nvidia Earnings

US stock futures fell ahead of Nvidia's (NVDA) first earnings release without Jensen Huang at the helm, a major event for the broader AI trade.

Futures on the Dow Jones Industrial Average (YM=F) and S&P 500 (ES=F) slipped 0.4%. Nasdaq-100 futures (NQ=F) also fell 0.4%, following a sell-off at the start of the week.

The focus is on Nvidia's earnings report after the bell, one of the week's biggest events alongside Anthropic's (ANTH.PVT) IPO on Thursday. Interim CEO Colette Kress will lead the earnings call following Huang's abrupt resignation last week amid allegations of affairs.

In other earnings news, Disney (DIS) will report results before the bell, with analysts expecting continued growth in its parks and streaming businesses. Home Depot (HD) will also report, providing insight into consumer spending on home improvement projects.

Investors will also watch economic data releases, including retail sales, export figures, and a housing market index. Yahoo Finance reports.

🧬 Summit Therapeutics (SMMT) Hits 52-Week Low After FDA Setback

Summit Therapeutics fell for a fifth straight day on Monday, hitting a new 52-week low after the Food and Drug Administration (FDA) rejected its Biologics License Application (BLA) for its lung cancer treatment candidate, ivonescimab, citing a lack of substantial evidence of improvement in overall survival.

In intraday trading, the stock dropped to a 52-week low of $11.54 before paring losses to end the day down 16.47% at $11.82 per share.

Summit Therapeutics Inc. (NASDAQ: SMMT) said the FDA rejected its BLA after determining that substantial evidence of effectiveness had not been established due to the absence of a statistically significant improvement in enrolled patients' overall survival.

Additionally, the FDA indicated that progression-free survival (PFS) data without any improvement in overall survival did not support a positive benefit-risk profile. Yahoo Finance reports.

🎬 Disney Expected to Post Another Strong Earnings Report, Led by Experiences and Streaming

Disney (DIS) is set to report fourth-quarter earnings on Tuesday before the market opens, as the media giant focuses on cutting costs and maintaining growth in its parks and streaming businesses.

For the quarter, Wall Street expects the company to report adjusted earnings per share of $1.68, alongside revenue of $25.2 billion, according to Bloomberg consensus data.

This will mark the third quarterly report under new CEO Josh D'Amaro, who took the reins on March 18. Wall Street analysts have shown confidence in the stock lately, with shares up 15% over the past six months.

The company's total operating income is expected to come in at $4.9 billion, in line with the guidance Disney shared last quarter. Disney's stock fell more than 1% before the bell on Tuesday. Yahoo Finance reports.

Top 5 Movers in Early Pre-Market

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) GP: GreenPower Motor Company Inc.
Total gain: +59.93%

2) AYTU: Aytu BioPharma, Inc.
Total gain: +45.05%

3) SPAI: Safe Pro Group Inc.
Total gain: +18.22%

4) BCTX: BriaCell Therapeutics Corp.
Total gain: +15.15%

5) AKAN: Akanda Corp.
Total gain: +13.12%

Yesterday's Biggest Movers

The closing price of the top three market percent gainers trading near or above $2 on Nov 16.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET). Stock Analysis reports.

1) NCT: Intercont (Cayman) Limited
Total gain: +44.05%

The stock appeared to be moving on no notable news.

2) CLRO: ClearOne, Inc.
Total gain: +41.84%

The stock appeared to be moving on no notable news.

3) BGIN: Bgin Blockchain Limited
Total gain: +35.05%

The stock appeared to be moving on no notable news.

Today’s Notable Earnings

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

JD

JD.com

Q3 2026

Before Market Open

Estimate: 0.930

Actual: 0.880

WB

Weibo

Q3 2026

Before Market Open

Estimate: 0.240

Actual: 0.060

TME

Tencent Music Enter Gr

Q3 2026

Before Market Open

Estimate: 0.210

Actual: 0.230

Today’s Economic Dates

Time (ET) / Report / Period

  • 8:30 AM / Retail Sales / Oct.
  • 8:30 AM / Import Prices / Oct.
  • 9:10 AM / Fed speech: Fed governor Christopher Waller

Parting Thoughts

“You shouldn’t expect to make money without bearing risk, but you shouldn’t expect to make money just for taking risk.”

— Howard Marks

Sourced in: The Indispensability of Risk — Oaktree Capital Management (April 17, 2024).

Disclaimer

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.

Copyright © TradeZero 2026. All rights reserved.

Related Articles